Showing results (151-160 of 1,393) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|September 4, 2025
Next-Generation Sequencing of Intraoperatively Acquired Cerebrospinal Fluid and Matched Tumor Tissue in Patients Undergoing Surgical Resection for GlioblastomaErica L Carpenter, Jacob E Till, Dominique Ballinger, et al.
JCO Precision Oncology|September 4, 2025
Real-World Validation of the Purity Independent Subtyping of Tumors Classifier for Informing Therapy Selection in Pancreatic Ductal AdenocarcinomaStephane Wenric, Chithra Sangli, John Guittar, et al.
JCO Precision Oncology|May 26, 2021
Mesenchymal Neuroblastoma Cells Are Undetected by Current mRNA Marker Panels: The Development of a Specific Neuroblastoma Mesenchymal Minimal Residual Disease PanelEsther M van Wezel, Lieke M J van Zogchel, Jalenka van Wijk, et al.
JCO Precision Oncology|May 26, 2021
CATCH: A Prospective Precision Oncology Trial in Metastatic Breast CancerMario Hlevnjak, Markus Schulze, Shaymaa Elgaafary, et al.
JCO Precision Oncology|May 26, 2021
Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid LeukemiaErica K Barnell, Kenneth F Newcomer, Zachary L Skidmore, et al.
JCO Precision Oncology|August 17, 2022
Tumor Mutational Burden as a Predictor of First-Line Immune Checkpoint Inhibitor Versus Carboplatin Benefit in Cisplatin-Unfit Patients With Urothelial CarcinomaRyon P Graf, Virginia Fisher, Richard S P Huang, et al.
JCO Precision Oncology|August 11, 2022
Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non-Small-Cell Lung Cancer Treated With Immune Checkpoint InhibitorsDiana Merino Vega, Katherine K Nishimura, Névine Zariffa, et al.
JCO Precision Oncology|August 11, 2022
Association of ERBB2 Copy Number and Gene Coalterations With Trastuzumab Efficacy and Resistance in Human Epidermal Growth Factor Receptor 2-Positive Esophagogastric and Gastric CancerKaori Hino, Tomohiro Nishina, Takeshi Kajiwara, et al.
JCO Precision Oncology|August 8, 2022
An Approach to Solving the Complex Clinicogenomic Data Landscape in Precision Oncology: Learnings From the Design of WAYFIND-R, a Global Precision Oncology RegistryChristophe Le Tourneau, Camille Perret, Allan Hackshaw, et al.
JCO Precision Oncology|September 3, 2021
Retrospective Case Series Analysis of RAF Family Alterations in Pancreatic Cancer: Real-World Outcomes From Targeted and Standard TherapiesAndrew Hendifar, Edik M Blais, Brian Wolpin, et al.
Pageof 140